Quote & Headlines
5d 1m 3m 1y 5y 10y
There are no Focus articles on SHPGF.
To learn more about Seeking Alpha PRO, click here.
There are no Transcripts on SHPGF.
There are no News articles on SHPGF.
SHPGF vs. ETF Alternatives
Monday, Jun 252012, 9:29 AMShares of drug maker Shire (SHPGY, SHPGF.PK) -13% in London trading on news the FDA approved a generic version of its attention-deficit and hyperactivity drug Adderall XR. Watson Pharma's (WPI) newly acquired Actavis division obtained an abbreviated new-drug application for the generic. SHPGY -12.2%, WPU +1.9% premarket. |Monday, Jun 252012, 9:29 AM| Comment!
Tuesday, Jun 122012, 9:07 AMBioMarin Pharmaceutical (BMRN) +4.8% premarket on rumors that Glaxo (GSK) is in advanced discussions toward a $5B buyout of BMRN. Last week, Shire (SHPGY, SHPGF.PK) also was said to be stalking the company. Glaxo is already engaged in a hostile $2.6B takeover bid for Human Genome Sciences. |Tuesday, Jun 122012, 9:07 AM| Comment!
Wednesday, Jun 222011, 9:52 AM